Begemann M - Search Results

1

Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.

Sommer IE, de Witte L, Begemann M, Kahn RS. Sommer IE, et al. Among authors: begemann m. J Clin Psychiatry. 2012 Apr;73(4):414-9. doi: 10.4088/JCP.10r06823. Epub 2011 Dec 13. J Clin Psychiatry. 2012. PMID: 22225599

2

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.

Sommer IE, Begemann MJ, Temmerman A, Leucht S. Sommer IE, et al. Schizophr Bull. 2012 Sep;38(5):1003-11. doi: 10.1093/schbul/sbr004. Epub 2011 Mar 21. Schizophr Bull. 2012. PMID: 21422107 Free PMC article. Review.

3

Estrogen augmentation in schizophrenia: a quantitative review of current evidence.

Begemann MJ, Dekker CF, van Lunenburg M, Sommer IE. Begemann MJ, et al. Schizophr Res. 2012 Nov;141(2-3):179-84. doi: 10.1016/j.schres.2012.08.016. Epub 2012 Sep 19. Schizophr Res. 2012. PMID: 22998932 Review.

4

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Sommer IE, et al. Schizophr Bull. 2014 Jan;40(1):181-91. doi: 10.1093/schbul/sbt139. Epub 2013 Oct 8. Schizophr Bull. 2014. PMID: 24106335 Free PMC article.

5

Cortical thickness in individuals with non-clinical and clinical psychotic symptoms.

van Lutterveld R, van den Heuvel MP, Diederen KM, de Weijer AD, Begemann MJ, Brouwer RM, Daalman K, Blom JD, Kahn RS, Sommer IE. van Lutterveld R, et al. Among authors: begemann mj. Brain. 2014 Oct;137(Pt 10):2664-9. doi: 10.1093/brain/awu167. Epub 2014 Jun 20. Brain. 2014. PMID: 24951640

6

Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.

Veerman SR, Schulte PF, Begemann MJ, Engelsbel F, de Haan L. Veerman SR, et al. Among authors: begemann mj. Pharmacopsychiatry. 2014 Sep;47(6):185-94. doi: 10.1055/s-0034-1383656. Epub 2014 Jul 7. Pharmacopsychiatry. 2014. PMID: 25002291 Review.

7

Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.

Veerman SR, Schulte PF, Begemann MJ, de Haan L. Veerman SR, et al. Among authors: begemann mj. Pharmacopsychiatry. 2014 Nov;47(7):231-8. doi: 10.1055/s-0034-1385930. Epub 2014 Aug 14. Pharmacopsychiatry. 2014. PMID: 25121994 Review.

8

Childhood trauma-specific reductions in limbic gray matter volume: still in the dark.

Begemann MJ, Schutte MJ, Sommer IE. Begemann MJ, et al. JAMA Psychiatry. 2015 Apr;72(4):398. doi: 10.1001/jamapsychiatry.2014.2680. JAMA Psychiatry. 2015. PMID: 25830676 No abstract available.

9

Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.

Heringa SM, Begemann MJ, Goverde AJ, Sommer IE. Heringa SM, et al. Among authors: begemann mj. Schizophr Res. 2015 Nov;168(3):603-13. doi: 10.1016/j.schres.2015.04.002. Epub 2015 Apr 23. Schizophr Res. 2015. PMID: 25914107 Review.

10

Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis.

Dauwan M, Begemann MJ, Heringa SM, Sommer IE. Dauwan M, et al. Among authors: begemann mj. Schizophr Bull. 2016 May;42(3):588-99. doi: 10.1093/schbul/sbv164. Epub 2015 Nov 7. Schizophr Bull. 2016. PMID: 26547223 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results